Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pamidronate disodium bulk supplier for pharma manufacturers

Pamidronate Disodium 15 mg, 30 mg, 60 mg, 90 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 15 mg, 30 mg, 60 mg, 90 mg

Reference Brands: Aredia (USA/EU)

Category: Osteoporosis

Pamidronate Disodium is a Osteoporosis product available as Injection in strengths 15 mg, 30 mg, 60 mg, 90 mg. It corresponds to the reference brand Aredia (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Pamidronate disodium is the disodium salt of the synthetic bisphosphonate pamidronate, widely used in the management of disorders associated with increased bone resorption. Although its exact mechanism of action is not fully understood, pamidronate disodium selectively binds to calcium phosphate crystals in bone tissue. By doing so, it inhibits osteoclast-mediated bone resorption, helping to reduce bone breakdown while preserving normal bone mineralization and formation.

Pamidronate disodium is commonly used to prevent bone loss and to treat osteoporosis, particularly in patients at high risk of fractures. It is also indicated for strengthening bone in Paget’s disease of bone and for preventing bone loss associated with long-term corticosteroid therapy. In oncology settings, pamidronate disodium plays an important role in managing skeletal complications in cancers with a high tendency to involve bone, such as multiple myeloma and metastatic malignancies.

Due to its ability to regulate calcium levels by promoting calcium sequestration in bone, pamidronate disodium is also used in the treatment of hypercalcemia. Additionally, it has been explored as an experimental therapy in certain rare bone disorders, including osteogenesis imperfecta, and has been studied for its potential benefits in complex regional pain syndrome.

Pamidronate Disodium — third party manufacturing & bulk supply

Pamidronate Disodium 15 mg, 30 mg, 60 mg, 90 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Pamidronate Disodium is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pamidronate Disodium listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Pamidronate Disodium →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Pamidronate disodium is used to treat conditions associated with increased bone resorption, including osteoporosis, Paget’s disease of bone, hypercalcemia of malignancy, and bone complications related to multiple myeloma and metastatic cancers.

Pamidronate disodium is a synthetic bisphosphonate compound that inhibits osteoclast-mediated bone resorption, helping to strengthen bone and reduce calcium loss.

The primary trade name of pamidronate disodium is Aredia.

Pamidronate disodium was originally developed and marketed under the brand name Aredia by Novartis, with multiple generic manufacturers now producing the injectable form.

The generic name of Aredia is pamidronate disodium.

The brand name of pamidronate disodium is Aredia.

Pamidronate disodium injection is manufactured globally by various pharmaceutical companies for distribution in the USA, EU, and UK markets.

Related Products

Strontium Ranelate

Strength:
2 g

Form: Sachet

Reference Brands: Osseor (EU/UK)

View Details
Abaloparatide

Strength:
80 mcg

Form: injection (prefilled syringe)

Reference Brands: Tymlos (USA), Eladynos (EU)

View Details
Calcitonin Salmon

Strength:
100 IU/mL, 200 IU/mL

Form: Injection / nasal spray

Reference Brands: Fortical (USA), Miacalcin (USA)

View Details
Risedronate Sodium

Strength:
5 mg, 30 mg, 35 mg, 75 mg, 150 mg

Form: Tablets

Reference Brands: Actonel (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.